You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

Screening High-Risk Populations for Lung Cancer

ID: 15-10 avr 2013
Type of Content: Guidelines & Advice, Clinical
Document Status: Archived
Authors:
H. Roberts, C. Walker-Dilks, K. Sivjee, Y. Ung, K. Yasufuku, A. Hey, N. Lewis , Lung Cancer Screening Guideline Development Group

Guideline Objective

To determine the appropriate use, if any, of LDCT in the screening of high-risk populations for lung cancer, including:

Patient considerations

  • Patient characteristics that define a high-risk population Test considerations.
  • The necessary elements involved in defining a positive result on LDCT and follow-up of a positive result.
  • The appropriate screening interval.
  • The appropriate screening duration.

Structural considerations that affect effectiveness and safety

  • Organized versus opportunistic screening.

Patient Population

Men and women considered at high risk for lung cancer based on their age and smoking history.

Intended Guideline Users

Provincial policy makers, primary care physicians, nurse practitioners, radiologists, respirologists, thoracic surgeons, thoracic oncologists, and any health professionals involved with patients who may be at risk for developing lung cancer.

pdf download Summary (PDF) (247.1 Ko)
pdf download Full Report (PDF) (731.06 Ko)